SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-076423
Filing Date
2024-06-28
Accepted
2024-06-28 18:12:46
Documents
1
Period of Report
2024-06-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2418494-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2418494-1_3seq1.xml 3 3360
  Complete submission text file 0001104659-24-076423.txt   4992
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Issuer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 5005 MCCONNELL AVENUE LOS ANGELES CA 90066
Business Address
Kyme Pierre (Reporting) CIK: 0002028892 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37544 | Film No.: 241087283